Search Results - "Yi, Jiqun"

Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial by Li, Xueying, Huang, He, Xu, Bing, Guo, Hongqiang, Lin, Yingcheng, Ye, Sheng, Yi, Jiqun, Li, Wenyu, Wu, Xiangyuan, Wang, Wei, Zhan, Hongyu, Xie, Derong, Peng, Jiewen, Cao, Yabing, Pu, Xingxiang, Guo, Chengcheng, Hong, Huangming, Wang, Zhao, Fang, Xiaojie, Zhou, Yong, Lin, Suxia, Liu, Qing, Lin, Tongyu

“…Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone administered every 3 weeks (R-CHOP-21) is the standard care for diffuse large B-cell…”
Get full text

The effectiveness and safety of the rapid titration strategy of background controlled-release oxycodone hydrochloride for patients with moderate-to-severe cancer pain: A retrospective cohort study by Feng, Weineng, Wang, Yufeng, Ran, Fengming, Mao, Yong, Zhang, Helong, Wang, Qifeng, Lin, Wen, Wang, Zhidong, Hu, Jianli, Liao, Wangjun, Zhang, Tao, Chu, Qian, Xiong, Weijie, Yi, Tienan, Yi, Jiqun, Ma, Shoucheng, Sun, Yi, Meng, Lingzhan, Liu, Chunling, Zhou, Silang, Zheng, Dengyun, Wang, Shubin, Lin, Haifeng, Fang, Wenzheng, Li, Jun, Wu, Minhui

“…BackgroundOxycodone hydrochloride is a semisynthetic narcotic analgesic agent. This study aimed to explore optimal titration strategy of controlled-release…”
Get full text

Efficacy, Safety, and Health-Related Quality of Life With Camrelizumab Plus Pemetrexed and Carboplatin as First-Line Treatment for Advanced Nonsquamous NSCLC With Brain Metastases (CAP-BRAIN): A Multicenter, Open-Label, Single-Arm, Phase 2 Study by Hou, Xue, Zhou, Chengzhi, Wu, Guowu, Lin, Wen, Xie, Zhanhong, Zhang, Haibo, Yi, Jiqun, Peng, Zheng, Yin, Lifeng, Ma, Chi, Chen, Likun

“…Systemic treatment options for NSCLC with brain metastases (BMs) are scarce. We evaluated the activity and safety of camrelizumab plus chemotherapy as…”
Get more information

Preliminary Clinical Validation of a Filtration-Based CTC Assay for Tumor Burden and HER2 Status Monitoring in Metastatic Breast Cancer by Wang, Xiuwen, Han, Chao, Liang, Jizhen, Yi, Jiqun, Pan, Zhaojun, Wang, Yadi

“…Bearing multidimensional tumor-relevant information ranging from genomic alterations to proteomic makeup, circulating tumor cells (CTCs) constitute a promising…”
Get more information

Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion by Wang, Lin, Sun, Yan, Yi, Jiqun, Wang, Xiuwen, Liang, Jizhen, Pan, Zhaojun, Li, Li, Jiang, Gaofeng

“…Background: Lung cancer is one of the most common and a lethal malignancy in the world and non-small cell lung cancer (NSCLC) is the most usual type. H19 long…”
Get full text

Extranodal natural killer T-cell lymphoma, nasal-type—A new staging system from CSWOG—A multicenter study by Lin, Tongyu, Hong, Huangming, Liang, Chaoyong, Huang, He, Guo, Chengcheng, Tian, Ying, Liu, Tingzhi, Zhang, Mengping, Li, Xueying, Fu, Xiaohong, Wang, Zhao, Fang, Xiaojie, Lin, Xiaoting, Li, Shanshan, Lin, Jia Tian, Prem, Raj Shrestha, Ye, Sheng, Yi, Jiqun, Deng, Yanhong, Xiao, Jian

“…Abstract only…”
Get full text